Recent advances in the development of protein–protein interactions modulators: mechanisms and clinical trials

H Lu, Q Zhou, J He, Z Jiang, C Peng, R Tong… - Signal transduction and …, 2020 - nature.com
Protein–protein interactions (PPIs) have pivotal roles in life processes. The studies showed
that aberrant PPIs are associated with various diseases, including cancer, infectious …

Asymmetric organocatalysis: an enabling technology for medicinal chemistry

B Han, XH He, YQ Liu, G He, C Peng… - Chemical Society Reviews, 2021 - pubs.rsc.org
The efficacy and synthetic versatility of asymmetric organocatalysis have contributed
enormously to the field of organic synthesis since the early 2000s. As asymmetric …

The role of ubiquitination in tumorigenesis and targeted drug discovery

L Deng, T Meng, L Chen, W Wei, P Wang - Signal transduction and …, 2020 - nature.com
Ubiquitination, an important type of protein posttranslational modification (PTM), plays a
crucial role in controlling substrate degradation and subsequently mediates the “quantity” …

Recent advances in organocatalytic asymmetric multicomponent cascade reactions for enantioselective synthesis of spirooxindoles

Y Wang, AA Cobo, AK Franz - Organic Chemistry Frontiers, 2021 - pubs.rsc.org
Asymmetric catalytic multicomponent cascade reactions have become indispensable tools
for enantioselective construction of spirooxindoles. In recent years, a number of successful …

p53 modifications: exquisite decorations of the powerful guardian

Y Liu, O Tavana, W Gu - Journal of molecular cell biology, 2019 - academic.oup.com
The last 40 years have witnessed how p53 rose from a viral binding protein to a central
factor in both stress responses and tumor suppression. The exquisite regulation of p53 …

[HTML][HTML] Role of p53 in breast cancer progression: An insight into p53 targeted therapy

C Marvalim, A Datta, SC Lee - Theranostics, 2023 - ncbi.nlm.nih.gov
The transcription factor p53 is an important regulator of a multitude of cellular processes. In
the presence of genotoxic stress, p53 is activated to facilitate DNA repair, cell cycle arrest …

The role of p53 in cancer drug resistance and targeted chemotherapy

K Hientz, A Mohr, D Bhakta-Guha, T Efferth - Oncotarget, 2016 - pmc.ncbi.nlm.nih.gov
Cancer has long been a grievous disease complicated by innumerable players aggravating
its cure. Many clinical studies demonstrated the prognostic relevance of the tumor …

Catalytic enantioselective construction of quaternary stereocenters: assembly of key building blocks for the synthesis of biologically active molecules

Y Liu, SJ Han, WB Liu, BM Stoltz - Accounts of chemical research, 2015 - ACS Publications
Conspectus The ever-present demand for drugs with better efficacy and fewer side effects
continually motivates scientists to explore the vast chemical space. Traditionally, medicinal …

Spirooxindoles: Promising scaffolds for anticancer agents

B Yu, DQ Yu, HM Liu - European journal of medicinal chemistry, 2015 - Elsevier
The search for novel anticancer agents with more selectivity and lower toxicity continues to
be an area of intensive investigation. The unique structural features of spirooxindoles …

MDM2, MDMX and p53 in oncogenesis and cancer therapy

M Wade, YC Li, GM Wahl - Nature Reviews Cancer, 2013 - nature.com
The MDM2 and MDMX (also known as HDMX and MDM4) proteins are deregulated in many
human cancers and exert their oncogenic activity predominantly by inhibiting the p53 tumour …